We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




First-Ever Rapid-Result Hematology Analyzer Measures Disease and Infection at POC

By HospiMedica International staff writers
Posted on 31 Mar 2023
Print article
Image: QScout RLD reports white blood cell count and differential from a drop of blood at patient-side in two minutes (Photo courtesy of Ad Astra)
Image: QScout RLD reports white blood cell count and differential from a drop of blood at patient-side in two minutes (Photo courtesy of Ad Astra)

Sepsis is a severe medical emergency that occurs when the body reacts strongly to an infection. This life-threatening condition is triggered by a chain reaction throughout the body, often starting from infections in the lung, urinary tract, skin, or gastrointestinal tract. Nearly any infection can lead to sepsis, which occurs when a localized infection progresses to severe infection throughout the body. According to a 2020 study, sepsis caused almost 11 million deaths worldwide in 2017, accounting for nearly 20% of all deaths in that year. Now, a new rapid-result hematology system comes with the capability to count immature infection-fighting granulocytes, one of the earliest markers for sepsis.

The QScout RLD rapid-result hematology system from Ad Astra Diagnostics, Inc. (AAD, Morrisville, NC, USA) is designed to measure white blood cell count, neutrophil-to-lymphocyte ratio, and counts of six white blood cell types in fingerstick or venous blood. QScout is the first hematology platform designed to quickly and accurately measure disease and infection, including a ratio of two white blood cell types (neutrophil-to-lymphocyte ratio) and count of immature granulocytes, at the point of care.

The QScout system uses a Rapid Leukocyte Differential (RLD) test that contains a dried reagent to stain cells. Whole blood is added to the test and inserted into the QScout Lab analyzer. The analyzer's optical system captures images of the cells, while an algorithm quickly identifies them, and results are displayed within two minutes. Ad Astra has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for the QScout RLD. The company aims to expedite the regulatory review process to obtain clearance for the system's use at the point of care, where faster results can improve health outcomes, and in the lab, where it can enhance efficiency.

“QScout RLD was designed as a quick, quantitative 'scout' for infection that is simple enough to operate yet robust enough to deliver reliable data patient-side,” said AAD's chief scientific officer and co-founder, Rudy Rodriguez. “In doing so, QScout RLD offers the potential to democratize access to quality diagnostics, while providing healthcare professionals with a potentially life-saving tool.”

Related Links:
Ad Astra Diagnostics 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Endoscope Tracking Software
T-DOC Endo

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.